Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Chang

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid TumorsYoonha Choi, Neekesh V Dharia, Tomi Jun, et al.
Nature Materials|November 13, 2023
Cell volume expansion and local contractility drive collective invasion of the basement membrane in breast cancerJulie Chang, Aashrith Saraswathibhatla, Zhaoqiang Song, et al.
Blood Advances|December 31, 2021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 studyGareth P Gregory, Shaji Kumar, Ding Wang, et al.
Blood|January 27, 2011
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformationDavide Rossi, Valeria Spina, Clara Deambrogi, et al.
The American Journal of Surgical Pathology|January 26, 2011
Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell componentCarlo Visco, Sylvia Hoeller, Jeffrey T Malik, et al.
Blood|June 3, 2011
miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapySantiago Montes-Moreno, Nerea Martinez, Beatriz Sanchez-Espiridión, et al.
The New England Journal of Medicine|August 23, 2023
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C MutationAdrian Sacher, Patricia LoRusso, Manish R Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2025
Single-Agent Divarasib in Patients With <i>KRAS G12C</i>-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I StudyAdrian G Sacher, Wilson H Miller, Manish R Patel, et al.
Nature Medicine|December 5, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trialJayesh Desai, Guzman Alonso, Se Hyun Kim, et al.
American Journal of Hematology|March 25, 2023
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centersKevin A David, Suchitra Sundaram, Seo-Hyun Kim, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid TumorsYoonha Choi, Neekesh V Dharia, Tomi Jun, et al.
Nature Materials|November 13, 2023
Cell volume expansion and local contractility drive collective invasion of the basement membrane in breast cancerJulie Chang, Aashrith Saraswathibhatla, Zhaoqiang Song, et al.
Blood Advances|December 31, 2021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 studyGareth P Gregory, Shaji Kumar, Ding Wang, et al.
Blood|January 27, 2011
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformationDavide Rossi, Valeria Spina, Clara Deambrogi, et al.
The American Journal of Surgical Pathology|January 26, 2011
Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell componentCarlo Visco, Sylvia Hoeller, Jeffrey T Malik, et al.
Blood|June 3, 2011
miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapySantiago Montes-Moreno, Nerea Martinez, Beatriz Sanchez-Espiridión, et al.
The New England Journal of Medicine|August 23, 2023
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a <i>KRAS</i> G12C MutationAdrian Sacher, Patricia LoRusso, Manish R Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2025
Single-Agent Divarasib in Patients With <i>KRAS G12C</i>-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I StudyAdrian G Sacher, Wilson H Miller, Manish R Patel, et al.
Nature Medicine|December 5, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trialJayesh Desai, Guzman Alonso, Se Hyun Kim, et al.
American Journal of Hematology|March 25, 2023
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centersKevin A David, Suchitra Sundaram, Seo-Hyun Kim, et al.
Pageof 5